Condition
Organophosphorus Poisoning
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (2)
Trial Status
Completed2
Withdrawn1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04393103Phase 2WithdrawnPrimary
Role of Intralipid in Management of Organophosphorus Poisoning
NCT06111352Phase 2CompletedPrimary
Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime
NCT06256796Not ApplicableUnknownPrimary
Fresh Frozen Plasma Transfusion in Acute Organophosphate Poisoning
NCT00947596Phase 1CompletedPrimary
A Study of Inhaled Atropine Sulfate in Healthy Adults
Showing all 4 trials